Macrocycles That Inhibit the Binding between Heat Shock Protein 90 and TPR-Containing Proteins
- 27 September 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 6 (12) , 1357-1366
Abstract
Heat shock protein 90 (Hsp90) accounts for 1–2% of the total proteins in normal cells and functions as a molecular chaperone that folds, assembles, and stabilizes client proteins. Hsp90 is overexpressed (3- to 6-fold increase) in stressed cells, including cancer cells, and regulates over 200 client and co-chaperone proteins. Hsp90 client proteins are involved in a plethora of cellular signaling events including numerous growth and apoptotic pathways. Since pathway-specific inhibitors can be problematic in drug-resistant cancers, shutting down multiple pathways at once is a promising approach when developing new therapeutics. Hsp90's ability to modulate many growth and signaling pathways simultaneously makes this protein an attractive target in the field of cancer therapeutics. Herein we present evidence that a small molecule modulates Hsp90 via binding between the N and middle domain and allosterically inhibiting the binding interaction between Hsp90 and four C-terminal binding client proteins: IP6K2, FKBP38, FKBP52, and HOP. These last three clients contain a tetratricopeptide-repeat (TPR) region, which is known to interact with the MEEVD sequence on the C-terminus of Hsp90. Thus, this small molecule modulates the activity between co-chaperones that contain TPR motifs and Hsp90's MEEVD region. This mechanism of action is unique from that of all Hsp90 inhibitors currently in clinical trials where these molecules have no effect on proteins that bind to the C-terminus of Hsp90. Further, our small molecule induces a Caspase-3 dependent apoptotic event. Thus, we describe the mechanism of a novel scaffold that is a useful tool for studying cell-signaling events that result when blocking the MEEVD-TPR interaction between Hsp90 and co-chaperone proteins.Keywords
This publication has 53 references indexed in Scilit:
- Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52)Current Opinion in Pharmacology, 2011
- Client-Loading Conformation of the Hsp90 Molecular Chaperone Revealed in the Cryo-EM Structure of the Human Hsp90:Hop ComplexMolecular Cell, 2011
- Design and synthesis of Hsp90 inhibitors: Exploring the SAR of Sansalvamide A derivativesBioorganic & Medicinal Chemistry, 2010
- Hsp90 as a Gatekeeper of Tumor Angiogenesis: Clinical Promise and Potential PitfallsJournal of Oncology, 2010
- Mechanistic Studies of Sansalvamide A-Amide: An Allosteric Modulator of Hsp90ACS Medicinal Chemistry Letters, 2010
- Species-Dependent Ensembles of Conserved Conformational States Define the Hsp90 Chaperone ATPase CycleMolecular Cell, 2008
- HSP90 regulates cell survival via inositol hexakisphosphate kinase-2Proceedings of the National Academy of Sciences, 2008
- Unliganded and hormone-bound glucocorticoid receptors interact with distinct hydrophobic sites in the Hsp90 C-terminal domainProceedings of the National Academy of Sciences, 2006
- The Hallmarks of CancerCell, 2000
- Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based ScreenScience, 1999